Goldman Sachs buys Celnor majority at €1bn valuation

Inflexion will sell a majority stake in testing and safety group Celnor to Goldman Sachs Alternatives at a reported €1bn valuation. Inflexion will retain a minority stake as Celnor expands in the US and Europe.